News

The European Commission (EC) has adopted the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) recommendation to grant Orphan Drug Designation (ODD) to Mundipharma and Cidara Therapeutics’ rezafungin for treating invasive candidiasis (IC). The European Commission (EC) has...

Humanetics has received funding from the US Department of Defense (DoD) to carry out a series of studies with its novel drug candidate, BIO 300, for Covid-19. The US DoD researchers discovered the drug candidate to create radio-protective drugs for...

Eli Lilly and Company, Vir Biotechnology, Inc. and GlaxoSmithKline plc announced a collaboration to evaluate a combination of two COVID-19 therapies in low-risk patients with mild to moderate COVID-19. Lilly has expanded its ongoing BLAZE-4 trial to evaluate the...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines confirmed that the Company is in discussion with the U.S. government to purchase an additional 100 million doses of the Moderna COVID-19 Vaccine for delivery in the...

Dr Reddy's Laboratories Ltd. and Global Response Aid FZCO (GRA) announced the termination of Avigan trial conducted in Kuwait focused on moderate to severe Covid patients in a hospital setting. The hospitalized patient study, conducted in Kuwait, on moderate to...

CEVA Logistics has signed a Memorandum of Understanding with Abu Dhabi Ports to work with the Hope Consortium. The Consortium is the umbrella organization of a UAE-based public-private partnership set up to address the logistical challenge of the worldwide...

Vaccine maker Bharat Biotech said that its coronavirus vaccine Covaxin has been found effective against the UK variant of the virus, which is considered 70 per cent more infectious than the Wuhan variety and is more lethal. In a...